Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study

Autor: Antonio Alcaraz, Alfredo Rodríguez-Antolín, Joaquín Carballido-Rodríguez, David Castro-Díaz, Manuel Esteban-Fuertes, José Cózar-Olmo, Vincenzo Ficarra, Rafael Medina-López, Jesús Fernández-Gómez, Javier Angulo, José Medina-Polo, Francisco Brenes-Bermúdez, José Molero-García, Antonio Fernández-Pro-Ledesma, José Manasanch, on behalf of The QUALIPROST Study Group

Publikováno v: Journal of Clinical Medicine, Vol 9, Iss 2909, p 2909 (2020)
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of Clinical Medicine
Volume 9
Issue 9
Digital.CSIC. Repositorio Institucional del CSIC
instname

To investigate whether tamsulosin (TAM) and the hexanic extract of Serenoa repens (HESr) are more effective in combination than as monotherapy in men with moderate-to-severe lower urinary tract symptoms associated with benign prostatic hyperplasia (L

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c538aecf3f320b53a72e76969861e810
https://www.mdpi.com/2077-0383/9/9/2909